Welcome Guest!  Login | Register | Help
Home News Screener Maps Groups Portfolio Insider Futures Forex Collaborate Store Elite
Settings
MELA [NASD]
MELA Sciences, Inc.
Index- P/E- EPS (ttm)-0.61 Insider Own0.70% Shs Outstand47.72M Perf Week-5.56%
Market Cap24.34M Forward P/E- EPS next Y- Insider Trans154.91% Shs Float47.11M Perf Month-26.09%
Income-25.90M PEG- EPS next Q- Inst Own18.90% Short Float8.59% Perf Quarter-28.17%
Sales0.50M P/S48.67 EPS this Y18.90% Inst Trans-28.86% Short Ratio7.98 Perf Half Y-33.77%
Book/sh0.18 P/B2.83 EPS next Y- ROA-121.00% Target Price1.00 Perf Year-55.26%
Cash/sh0.08 P/C6.40 EPS next 5Y25.00% ROE-174.10% 52W Range0.51 - 1.39 Perf YTD-20.31%
Dividend- P/FCF- EPS past 5Y11.10% ROI-291.60% 52W High-62.24% Beta0.08
Dividend %- Quick Ratio0.80 Sales past 5Y- Gross Margin- 52W Low2.92% ATR0.04
Employees45 Current Ratio1.80 Sales Q/Q0.00% Oper. Margin- RSI (14)33.27 Volatility6.68% 6.20%
OptionableYes Debt/Eq0.00 EPS Q/Q47.40% Profit Margin- Rel Volume0.19 Prev Close0.51
ShortableYes LT Debt/Eq0.00 EarningsMay 05 Payout- Avg Volume507.05K Price0.52
Recom2.00 SMA20-13.67% SMA50-22.14% SMA200-28.26% Volume76,070 Change2.92%
24-Sep-12Upgrade WBB Securities Hold → Speculative Buy $2 → $4
02-Nov-11Reiterated Needham Buy $14 → $20
17-Nov-10Upgrade WBB Securities Sell Short → Hold $5 → $2
10-Sep-10Initiated BioLogic Equity Research Sell
11-May-10Downgrade Brean Murray Buy → Hold
31-Mar-10Initiated Brean Murray Buy $9
25-Mar-10Downgrade WBB Securities Sell → Sell Short $7.25 → $5
25-Mar-10Downgrade Roth Capital Hold → Sell $12 → $4
30-Nov-09Initiated WBB Securities Sell $7.25
12-Nov-09Initiated Boenning & Scattergood Outperform $12.50
28-Oct-09Downgrade Roth Capital Buy → Hold $9 → $12
18-Aug-09Initiated Oppenheimer Outperform $11
13-Feb-09Initiated Caris & Company Buy $9
13-May-08Reiterated Jesup & Lamont Buy $8 → $9.50
19-Mar-08Initiated Jesup & Lamont Buy $8
09-Apr-14 08:46AM  MELA SCIENCES, INC. /NY Files SEC form 8-K, Change in Directors or Principal Officers, Financial Statements and Exhib EDGAR Online +5.56%
08:23AM  Medical Diagnostic Developer MELA Sciences Appoints Senior Healthcare Finance Executive Robert W. Cook as CFO Business Wire
02-Apr-14 04:39PM  MELA SCIENCES, INC. /NY Files SEC form 8-K/A, Termination of a Material Definitive Agreement EDGAR Online
01-Apr-14 02:47PM  MELA SCIENCES, INC. /NY Files SEC form 8-K, Termination of a Material Definitive Agreement EDGAR Online
21-Mar-14 01:04PM  MELA SCIENCES, INC. /NY Financials EDGAR Online Financials
17-Mar-14 07:49PM  MELA Sciences' CEO Discusses Q4 2013 Results - Earnings Call Transcript at Seeking Alpha
04:30PM  MELA Sciences Earnings Call scheduled for 4:30 pm ET today CCBN
04:07PM  MELA SCIENCES, INC. /NY Files SEC form 8-K, Results of Operations and Financial Condition, Change in Directors or Pri EDGAR Online
04:00PM  MELA Sciences Announces 2013 Fourth Quarter and Year-End Financial Results Business Wire
07:34AM  MELA Sciences Earnings Call scheduled for 4:30 pm ET today CCBN
07:07AM  Q4 2013 MELA Sciences Earnings Release - After Market Close CCBN
14-Mar-14 07:55AM  Optical Diagnostic Developer, MELA Sciences, Appoints Veteran Medical Device Investment Banker, Samuel Navarro, as Director Business Wire -7.04%
07:55AM  Optical Diagnostic Developer, MELA Sciences, Appoints Veteran Medical Device Investment Banker, Samuel Navarro, as Director
11-Mar-14 10:35AM  MELA Sciences, Inc. (MELA) Pioneering Earlier Detection of Melanoma Is Featured in Flaherty Financial News Newsletter #41 Marketwired -7.79%
06-Mar-14 09:36AM  Dermatology Diagnostic Developer, MELA Sciences, to Host Q4 Conference Call Monday, March 17, 2014 at 4:30 pm ET Business Wire
09:36AM  Dermatology Diagnostic Developer, MELA Sciences, to Host Q4 Conference Call Monday, March 17, 2014 at 4:30 pm ET
25-Feb-14 11:03AM  Rose Crane, CEO of Melanoma Diagnostics Provider, MELA Sciences, to Be Interviewed Live Today on Clear Channel Business Talk Radio DFW1190AM Marketwired
24-Feb-14 08:00AM  MELA Sciences receives extension to meet NASDAQ minimum bid price theflyonthewall.com
08:00AM  MELA Sciences receives extension to meet NASDAQ minimum bid price
07:55AM  Melanoma Diagnostic Provider, MELA Sciences Receives 180-Day Extension to Meet NASDAQ Minimum Bid Price Business Wire
07:55AM  Melanoma Diagnostic Provider, MELA Sciences Receives 180-Day Extension to Meet NASDAQ Minimum Bid Price
21-Feb-14 01:12PM  MELA SCIENCES, INC. /NY Files SEC form 8-K, Other Events, Financial Statements and Exhibits EDGAR Online
06-Feb-14 01:57PM  MELA Sciences' CEO Presents at SeeThruEquity Winter Microcap Investor Conference (Transcript) at Seeking Alpha +5.80%
01:57PM  MELA Sciences' CEO Presents at SeeThruEquity Winter Microcap Investor Conference (Transcript)
05-Feb-14 05:15PM  MELA Sciences Completes Private Placement to Institutional Investors and MELA Sciences Directors Business Wire
05:15PM  MELA Sciences Completes Private Placement to Institutional Investors and MELA Sciences Directors
03-Feb-14 07:55AM  Melanoma Diagnostic Provider, MELA Sciences Provides Details of Recent $12.45 Million Private Placement Business Wire
07:55AM  Melanoma Diagnostic Provider, MELA Sciences Provides Details of Recent $12.45 Million Private Placement
07:40AM  MELA SCIENCES, INC. /NY Files SEC form 8-K, Entry into a Material Definitive Agreement, Amendments to Articles of Inc EDGAR Online
31-Jan-14 02:03PM  CORRECTING and REPLACING Melanoma Diagnostic Provider, MELA Sciences, to Raise $12.45 Million in Private Placement to Institutional Investors and MELA Sciences Directors Business Wire
02:03PM  CORRECTING and REPLACING Melanoma Diagnostic Provider, MELA Sciences, to Raise $12.45 Million in Private Placement to Institutional Investors and MELA Sciences Directors
09:50AM  MELA Sciences enters $12.45M in private placement at theflyonthewall.com
09:50AM  MELA Sciences enters $12.45M in private placement
09:44AM  Melanoma Diagnostic Provider, MELA Sciences, to Raise $12.45 Million in Private Placement to Institutional Investors and MELA Sciences Directors Business Wire
30-Jan-14 07:55AM  Dermatologist Highlights Medical Benefits of MelaFind Device in Aiding Melanoma Diagnosis at Most Treatable Stage Business Wire +8.70%
07:55AM  Dermatologist Highlights Medical Benefits of MelaFind Device in Aiding Melanoma Diagnosis at Most Treatable Stage
27-Jan-14 07:55AM  Medical Diagnostic Developer MELA Sciences to Present at SeeThruEquity Microcap Conf. Feb. 6 in NYC and to Exhibit at Maui Dermatology Conf. Jan. 26-30 Business Wire -5.80%
07:55AM  Medical Diagnostic Developer MELA Sciences to Present at SeeThruEquity Microcap Conf. Feb. 6 in NYC and to Exhibit at Maui Dermatology Conf. Jan. 26-30
22-Jan-14 07:55AM  MELA Sciences Announces the Results of its Third Clinical Advisory Meeting and the Four Clinical Posters Presented at the Winter Clinical Dermatology Conference Business Wire
07:55AM  MELA Sciences Announces the Results of its Third Clinical Advisory Meeting and the Four Clinical Posters Presented at the Winter Clinical Dermatology Conference
16-Jan-14 07:55AM  Melanoma Diagnostic Developer MELA Sciences Hosts Clinical Advisory Meeting & Exhibits Four Clinical Posters at Winter Clinical Dermatology Conference - January 17 - 22 Business Wire +7.35%
07:55AM  Melanoma Diagnostic Developer MELA Sciences Hosts Clinical Advisory Meeting & Exhibits Four Clinical Posters at Winter Clinical Dermatology Conference - January 17 - 22
06-Jan-14 08:01AM  MELA SCIENCES, INC. /NY Files SEC form 8-K, Change in Directors or Principal Officers, Financial Statements and Exhib EDGAR Online +7.69%
08:01AM  MELA SCIENCES, INC. /NY Files SEC form 8-K, Change in Directors or Principal Officers, Financial Statements and Exhib
02-Jan-14 08:00AM  MELA Sciences Appoints Healthcare Executive Jeff ODonnell as Director and Streamlines Board to Support Refocused Go-to-Market Strategy Business Wire
08:00AM  MELA Sciences Appoints Healthcare Executive Jeff ODonnell as Director and Streamlines Board to Support Refocused Go-to-Market Strategy
09-Dec-13 12:47PM  MELA Sciences Reports Positive Reception for its Optical Melanoma Diagnostic Device at Clinical Advisory Meeting and Mount Sinai Winter Dermatology Symposium Business Wire
12:47PM  MELA Sciences Reports Positive Reception for its Optical Melanoma Diagnostic Device at Clinical Advisory Meeting and Mount Sinai Winter Dermatology Symposium
06-Dec-13 07:56AM  Melanoma Diagnostics Leader, MELA Sciences, Inc., Participates in Skin Cancer Diagnostic Workshop with Leading German Dermatologists, Hosted by Germanys Augsburg Clinic Business Wire
07:56AM  Melanoma Diagnostics Leader, MELA Sciences, Inc., Participates in Skin Cancer Diagnostic Workshop with Leading German Dermatologists, Hosted by Germanys Augsburg Clinic
05-Dec-13 07:56AM  Melanoma Diagnostics Leader, MELA Sciences, Hosts Clinical Advisory Meeting Friday, Dec. 6th in Conjunction with Mount Sinai Winter Dermatology Symposium Business Wire
07:56AM  Melanoma Diagnostics Leader, MELA Sciences, Hosts Clinical Advisory Meeting Friday, Dec. 6th in Conjunction with Mount Sinai Winter Dermatology Symposium
03-Dec-13 06:03AM  Solta Medical (SLTM) in Focus: Stock Moves Up 5.5% Zacks
06:03AM  Solta Medical (SLTM) in Focus: Stock Moves Up 5.5%
15-Nov-13 01:04PM  MELA SCIENCES, INC. /NY Financials EDGAR Online Financials
01:04PM  MELA SCIENCES, INC. /NY Financials
12-Nov-13 04:11PM  MELA SCIENCES, INC. /NY Files SEC form 8-K, Change in Directors or Principal Officers, Financial Statements and Exhib EDGAR Online
04:11PM  MELA SCIENCES, INC. /NY Files SEC form 8-K, Change in Directors or Principal Officers, Financial Statements and Exhib
08-Nov-13 03:33PM  MELA SCIENCES, INC. /NY Files SEC form 10-Q, Quarterly Report EDGAR Online
03:33PM  MELA SCIENCES, INC. /NY Files SEC form 10-Q, Quarterly Report
06-Nov-13 07:28PM  MELA Sciences Management Discusses Q3 2013 Results - Earnings Call Transcript at Seeking Alpha -5.48%
07:28PM  MELA Sciences Management Discusses Q3 2013 Results - Earnings Call Transcript
04:06PM  MELA SCIENCES, INC. /NY Files SEC form 8-K, Results of Operations and Financial Condition, Financial Statements and E EDGAR Online
04:06PM  InPlay: MELA Sciences appoints Rose Crane as President and Chief Executive Officer and a Director, Effective as of Nov 11th Briefing.com
04:05PM  MELA Sciences, a Leader in Melanoma Diagnostics, Appoints Rose Crane as President and Chief Executive Officer and a Director, Effective as of Monday, November 11th GlobeNewswire
04:02PM  MELA Sciences, a Leader in Melanoma Diagnostics, Reports Third Quarter 2013 Results and Launch of New Strategic Plan GlobeNewswire
07:07AM  Q3 2013 MELA Sciences Earnings Release - After Market Close CCBN
01-Nov-13 08:00AM  MELA Sciences, Inc. Closes $6.0 Million Registered Offering GlobeNewswire
30-Oct-13 05:26PM  MELA SCIENCES, INC. /NY Files SEC form 8-K, Entry into a Material Definitive Agreement, Financial Statements and Exhi EDGAR Online -14.29%
08:03AM  InPlay: MELA Sciences announces $6.0 mln registered offering Briefing.com
08:00AM  MELA Sciences, Inc. Announces $6.0 Million Registered Offering GlobeNewswire
25-Oct-13 08:00AM  MELA Sciences, Inc., a Leader in the Fight Against Melanoma, Participates in the Washington D.C. Dermatological Society's Fall Clinical Conference GlobeNewswire -10.10%
21-Oct-13 08:04AM  InPlay: MELA Sciences: New data presented at the fall clinical dermatology conference supports MelaFind as a fundamental tool for dermatologists Briefing.com
08:00AM  New Data Presented at the Fall Clinical Dermatology Conference Supports MelaFind(R) as a Fundamental Tool for Dermatologists GlobeNewswire
16-Oct-13 08:00AM  MELA Sciences, Inc. to Participate in the Fall Clinical Dermatology Conference GlobeNewswire
15-Oct-13 08:00AM  MelaFind┬« Featured On "The Rachael Ray Show" PR Newswire
14-Oct-13 04:05PM  MELA Sciences, a Leader in the Fight Against Melanoma, to Release Third Quarter 2013 Financial Results and Host Conference Call on Wednesday, November 6, 2013 GlobeNewswire
02-Oct-13 08:00AM  MELA Sciences, Inc., a Leader in the Fight Against Melanoma, Participates in the American Society of Dermatologic Surgery Annual Meeting PR Newswire
01-Oct-13 08:00AM  MELA Sciences, a Leader in the Fight Against Melanoma, Appoints Dr. Darrell Rigel as Chief Medical Advisor to Its Board of Directors GlobeNewswire
30-Sep-13 08:32AM  MELA SCIENCES, INC. /NY Files SEC form 8-K, Change in Directors or Principal Officers, Financial Statements and Exhib EDGAR Online
08:00AM  MELA Sciences, a Leader in the Fight Against Melanoma, Appoints Tony Dimun to Its Board of Directors GlobeNewswire
25-Sep-13 07:00AM  MELA Sciences, Inc. a Leader in the Fight Against Melanoma, Exhibiting MelaFind(R) at the German Skin Cancer Congress GlobeNewswire
19-Sep-13 01:40PM  PerkinElmer Upgraded to Neutral Zacks
17-Sep-13 01:50PM  Varian Medical Stays Neutral Zacks -5.33%
12-Sep-13 04:31PM  MELA SCIENCES, INC. /NY Files SEC form 8-K, Termination of a Material Definitive Agreement EDGAR Online
03-Sep-13 12:41AM  Skin-Cancer Groups Push for More Checkups at The Wall Street Journal
02-Sep-13 10:59PM  Skin-Cancer Groups Push for More Checkups at The Wall Street Journal
28-Aug-13 04:32PM  MELA SCIENCES, INC. /NY Files SEC form 8-K, Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Sta EDGAR Online
20-Aug-13 01:04PM  MELA SCIENCES, INC. /NY Financials EDGAR Online Financials -5.63%
16-Aug-13 01:04PM  MELA SCIENCES, INC. /NY Financials EDGAR Online Financials
07-Aug-13 10:30PM  MELA Sciences Management Discusses Q2 2013 Results - Earnings Call Transcript at Seeking Alpha -5.56%
04:27PM  MELA Sciences, Inc. Management Discusses Q2 2013 Results (Webcast) at Seeking Alpha
04:06PM  MELA SCIENCES, INC. /NY Files SEC form 8-K, Results of Operations and Financial Condition, Other Events, Financial St EDGAR Online
04:05PM  MELA Sciences, a Leader in the Fight Against Melanoma, Announces Second Quarter 2013 Financial Results; Announces Restructuring GlobeNewswire
07:07AM  Q2 2013 MELA Sciences Earnings Release - After Market Close CCBN
02-Aug-13 12:17PM  Medical Device Manufacturers Take Technologies Abroad, Design for International Markets First Before Commercializing Devices in U.S. Wall Street Transcript
22-Jul-13 02:07PM  Netflixs Assertions, AstraZeneca Hits Employee Snag in China, and 3 More Hot Stocks at Wall St. Cheat Sheet
08:00AM  MELA Sciences, Inc., A Leader In The Fight Against Melanoma, Hosts Symposium At 8th World Congress Of Melanoma PR Newswire
17-Jul-13 04:05PM  MELA Sciences, a Leader in the Fight Against Melanoma, to Release Second Quarter 2013 Financial Results and Host Conference Call on Wednesday, August 7, 2013 GlobeNewswire
11-Jul-13 10:40PM  MELA Sciences, Inc. - Special Call at Seeking Alpha -5.94%
MELA Sciences, Inc., a medical device company, designs, develops, and commercializes a non-invasive point-of-care instrument to aid in the detection of melanoma. The company's principal product, MelaFind, consists of a hand-held component that emits light of multiple wavelengths to capture digital data from clinically atypical pigmented skin lesions, which is then analyzed utilizing classification algorithms trained on its proprietary database of melanomas and benign lesions to provide information to assist in the management of the patient's disease, including information useful in the decision of whether to biopsy the lesion. MELA Sciences, Inc. offers its product to dermatologists. The company was formerly known as Electro-Optical Sciences, Inc. and changed its name MELA Sciences, Inc. in April 2010. MELA Sciences, Inc. was founded in 1989 and is based in Irvington, New York.
Insider Trading Relationship Date Transaction Cost #Shares Value ($) #Shares Total SEC Form 4
Via LuAnnDirectorFeb 05Buy0.7413,51310,00028,513Feb 06 03:29 PM
DIMUN ANTHONY JDirectorFeb 05Buy0.7413,51310,00013,513Feb 06 03:16 PM
Swintek Kathryn BDirectorFeb 05Buy0.7413,51310,00033,513Feb 06 02:58 PM
Crane Rosemary ACEO and PresidentFeb 05Buy0.7467,57050,00267,570Feb 06 12:53 PM
Coradini RobertChairmanFeb 05Buy0.7467,56750,000139,024Feb 06 12:29 PM
STONE DAVID KDirectorFeb 05Buy0.7413,51410,00023,514Feb 06 04:12 PM
ODONNELL JEFFREY FDirectorFeb 05Buy0.7413,51310,00013,513Feb 10 04:54 PM
Coradini RobertInterim CEOJun 27Buy0.8715,00013,04115,000Jun 27 03:37 PM
Egger Anne MDirectorJun 27Buy0.9011,0009,89316,350Jun 27 04:02 PM
Steinhart Richard IChief Financial OfficerJun 25Buy0.813,0002,4274,000Jun 25 11:25 AM
Coradini RobertInterim CEOJun 24Buy0.7250,00035,99071,457Jun 24 12:48 PM
Swintek Kathryn BDirectorJun 24Buy0.7317,00012,39320,000Jun 24 12:57 PM
Swintek Kathryn BDirectorJun 21Buy0.793,0002,3703,000Jun 21 10:15 AM
MEADS MINDY CDirectorJun 20Buy0.795,0704,0025,070Jun 25 03:58 PM
Gulfo Joseph VChairman, CEO & PresidentMay 03Buy1.0825,00027,000208,311May 03 09:50 AM